Form 4: Twist Bioscience CEO Emily Leproust Reports Stock Sale to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Emily Leproust, CEO of Twist Bioscience, sold 2,790 shares of common stock on February 21, 2025, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

  • On February 21, 2025, Emily M. Leproust, CEO of Twist Bioscience Corp, sold 2,790 shares of common stock at a price of $44.177 per share.
  • The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
  • Following the transaction, Leproust directly owns 665,094 shares of Twist Bioscience common stock.
  • Leproust also holds various employee stock options with different exercise prices and expiration dates.
  • These options include those granted in September 2020 that vested on December 19, 2022, due to the achievement of performance criteria.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing a stock sale for tax purposes, which is neutral in sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale of shares to cover tax obligations is a common practice.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but it is unlikely to be significant given the relatively small number of shares sold.

Key Dates

DateDescription
12/19/2022Performance stock options granted on September 1, 2020, vested and became exercisable as a result of meeting performance criteria.
02/21/2025Date of the stock sale transaction.
02/25/2025Date of the signature on the Form 4 filing.
09/28/2025Expiration date for one set of employee stock options.
09/28/2027Expiration date for one set of employee stock options.
11/18/2028Expiration date for one set of employee stock options.
10/23/2029Expiration date for one set of employee stock options.
08/31/2030Expiration date for one set of employee stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.